Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2015

Mar 17, 2015

34978_dirs_2015-03-16_b74eb4b1-f2c3-40ea-a9f8-dd694a0cdb09.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2015-02-27

Reporting Person: MOORE WILLIAM M (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-27 Common Stock M 190000 Acquired 342396 Direct
2015-03-13 Common stock F 61465 $9.08 Disposed 280931 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-27 Performance Rights $ M 190000 Disposed 2015-02-27 Common Stock (190000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 78944 Indirect

Footnotes

F1: Represents shares of Common stock issued upon the vesting of performance rights granted on March 25, 2013.

F2: The RSU's convert into the Issuer's Common Stock on a one-for-one basis.

F3: The performance right represents a contingent right to receive up to 220,000 shares of IRIDEX common stock. The number of shares issuable pursuant to the performance right was determined on February 27, 2015 based upon the Company's average stock price performance of fair market value, as set forth within a Restricted Stock Unit Award Agreement between IRIDEX and the reporting person.